Canadian life sciences firm Rapid Infection Diagnostics Inc. adds Mario Savarese to its Strategic Advisory Board to bolster its diagnostic development efforts.
The company announced the appointment of Mario Savarese to its Strategic Advisory Board, which is a routine governance matter with no immediate financial impact.
Rapid Infection Diagnostics Inc. (RID) has expanded its Strategic Advisory Board with the appointment of Mario Savarese. The Calgary-based life sciences firm continues to focus on its core mission of leveraging metabolomics for rapid infectious disease diagnostics.
The company specializes in the use of metabolomics for the rapid diagnosis of infectious diseases.